Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioStock: Large shareholders about their increased holding in Chordate Medical

Last week, Chordate Medical announced that two major shareholders, Isac Brandberg AB and related parties and Jinderman & Partners AB, have increased their shareholding in the company. This is a clear sign of the two shareholders’ confidence in Chordate Medical and the company’s treatment for chronic nasal congestion and chronic migraine. BioStock contacted two representatives from Jinderman & Partners and Isac Brandberg to hear more about their expectations on Chordate Medical and why they have chosen to increase their holdings in the company.Read the full article at biostock.se:https://

New number of votes in AB Volvo

The number of votes in AB Volvo has changed due to the conversion of a total of 425 400 Series A shares to a total of 425 400 Series B shares. The conversions were implemented with the support of the opportunity for Series A shareholders to request conversion of Series A shares to Series B shares which was entered in the Articles of Association at the 2011 Annual General Meeting.Today, 26 February 2021, the last trading day of the month, there are a total of 2,033,452,084 registered shares in AB Volvo. Of these are 444,987,946 Series A shares and 1,588,464,138 Series B shares. The number of

Skanska Financial Services AB (publ)’s year-end report, January–December 2020, available on website

Skanska Financial Services AB (publ)’s year-end report for January–December 2020 is now available in Swedish on Skanska's website, at https://group.skanska.com/investors/funding/skanska-financial-services-ab/.This information is information that Skanska Financial Services AB (publ) is obliged to make public pursuant to Nasdaq Stockholm’s Rule Book for Issuers of Fixed Income Instruments. The information was submitted for publication at 1:00 pm CET on February 26, 2021. Download the full report here:  https://group.skanska.com/investors/reports-publications/

The Finnish Financial Supervisory Authority has approved a supplement to the prospectus prepared for the merger of Altia Plc and Arcus ASA

ALTIA PLC  STOCK EXCHANGE RELEASE 26 FEBRUARY 2021 AT 1:35 p.m. EET THIS STOCK EXCHANGE RELEASE MAY NOT BE PUBLISHED OR DISTRIBUTED, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR RULES OR WOULD REQUIRE ADDITIONAL DOCUMENTS TO BE COMPLETED OR REGISTERED OR REQUIRE ANY MEASURE TO BE UNDERTAKEN IN ADDITION TO THE REQUIREMENTS UNDER FINNISH LAW. FOR FURTHER INFORMATION, SEE “IMPORTANT NOTICE” BELOW. The Finnish Financial Supervisory

Pihlajalinna Plc: Managers’ transactions

Pihlajalinna Plc      Managers’ transactions     26 February 2021 at 1:30 p.m. Pihlajalinna Plc: Managers’ transactions Pihlajalinna Plc has received the following notification on 26 February 2021: Person subjectto thenotificationrequirementName: Elina HeliöPosition: Other senior manager     InitialNotificationReference 74370058MTRLEDOCHV67_20210226114125_2number:     IssuerName: Pihlajalinna OyjLEI: 74370058MTRLEDOCHV67

Pihlajalinna Plc: Managers’ transactions

Pihlajalinna Plc      Managers’ transactions     26 February 2021 at 1:30 p.m. Pihlajalinna Plc: Managers’ transactions Pihlajalinna Plc has received the following notification on 26 February 2021: Person subjectto thenotificationrequirementName: Rantala Tarja KristiinaPosition: Chief Financial Officer     InitialNotificationReference 74370058MTRLEDOCHV67_20210225164833_2number:     IssuerName: Pihlajalinna OyjLEI:

Helbio announce an order to deliver a CHP system to Brunel University in London

Metacon subsidiary Helbio is pleased to announce receipt of an order from Brunel University, London, for an advanced H2PS-5 CHP system which will be capable to operate on three different fuels, namely Natural Gas, LPG and pure hydrogen, without any modifications in hardware. The value of the order is just short about €70k.The CEO of Helbio, Xenophon Verykios, commented: “To the best of our knowledge, this is the only system worldwide which can operate on multiple fuels without any hardware modification, but only by software selection. This feature gives great flexibility to the CHP system

A STRONG FINISH TO A CHALLENGING YEAR

DELETE GROUP OYJ Stock Exchange Release 26 February 2021 at 1.15 p.m. (EET)Financial Statements Bulletin January–December 2020 (IFRS, IAS 34, unaudited) A STRONG FINISH TO A CHALLENGING YEAR Demolition Services is reported in this report in accordance with IFRS 5 “Assets Held for Sale and Discontinued Operations” and is not included in the financials for continuing operations. More information is in the notes section. KEY POINTS: OCTOBER–DECEMBER 2020 · Net sales decreased by 3% to EUR 32.4 (Q4 2020: 33.5) million · EBITDA increased by EUR 0.5 million to EUR 2.2 (1.7)

Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)

Lund, Sweden, 12:00 pm CET, 26 February 2021 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone injuries, today announced a change in the number of shares and votes. During February, the number of shares and votes in BONESUPPORT HOLDING AB (publ) has increased with 10,000 due to the exercise of warrants. As of 28 February 2021, the number of shares in BONESUPPORT HOLDING AB (publ) amounts to 65,009,222 shares, of which 63,774,222 are ordinary shares with one vote per share and 1,235,000 are series C shares with one-tenth of a vote per share.

Nordax Annual Report and Sustainability Report has been published

The reports are available at https://www.nordaxgroup.com/investors/financial-reports/ For further information, please contact: Patrick McArthur, CFO, Nordax Tel: +46 760 32 69 70 E-post: ir@nordax.se   About Nordax Nordax Bank is a leading specialist bank in Northern Europe owned by Nordic Capital Fund VIII and Sampo. We currently have around 255,000 private customers in Sweden, Norway, Finland, Denmark and Germany. We are a specialist bank that through responsible lending helps people make informed decisions for a life they can afford. We are a flexible complement

Qred’s year-end report: have helped more than 10,000 customers during Corona

2020 is a year that we won’t forget anytime soon. Despite the pandemic, small business financer Qred reports a strong result with increased revenues of 56 % compared to the previous year. During 2020, Qred powered over 10,000 small businesses - a segment hit hard by the Corona outbreak and subsequent restrictions.  Stockholm, February 26, 2021 - Today, fintech company and small business financier Qred releases its report for last year’s fourth quarter. During a year filled with pandemic and restrictions, Qred has helped and powered more than 10,000 small businesses in six

Qred releases report for Q4: continued strong growth

Today, fintech company Qred releases its report for last year’s fourth quarter and reports continued growth despite the pandemic. The company reports an operating income increase by 56.5 % compared to the previous year. During 2020, Qred helped more than 10,000 small businesses - a segment hit hard by the Corona outbreak and subsequent restrictions.Results for the same period for the previous year are stated in brackets. October - December 2020 · Operating income increased by 39.6% to SEK 74.7 m (53.5) · Commission income amounted to SEK 35.8 m (1.0) · Interest income

Dentalum Operations AB (publ.) Q4 Interim Report

During 2020, Dentalum has acquired eleven dental clinics (of which five during the fourth quarter) and, as per December 31, 2020, the Group consists of twelve clinics operating in five regions in Sweden.Fourth Quarter and FY 2020 – unaudited · Reported operating revenues in FY 2020 amounts to SEK 57.9 million (SEK 1.8 million) of which SEK 31.9 million were generated during the fourth quarter.  · EBITDA amounts to SEK 5.4 million for FY 2020 (SEK 0.37 million), of which SEK 3.0 million in the fourth quarter. · Operating cash flow during FY 2020 amounts to SEK 5.3 million of which

DIAGNODE-2 results and meta-analysis with Diamyd[®] to be presented at diabetes conference

Results from the phase IIb trial DIAGNODE-2 with intralymphatic administration of Diamyd[®] as well as the large-scale meta-analysis comprising data from more than 600 individuals treated with Diamyd[®] showing significant treatment effect in individuals carrying the HLA DR3-DQ2 haplotype, will be presented as oral abstracts by Professor Johnny Ludvigsson and PhD Ulf Hannelius, CEO of Diamyd Medical at the Scandinavian Society of the Science in Diabetes (SSSD) on March 11, 2021.The abstracts will be presented during the conference session “Diabetes classification and precision medicine”.

BillerudKorsnäs EVP Commercial leaves the company during 2021

BillerudKorsnäs EVP Commercial, Helene Biström, today announced that she has decided to leave the company at her own request.BillerudKorsnäs will immediately initiate the recruitment process of a new EVP Commercial and announcement of a replacement will be done in due course.“Helene Biström, currently in the role of EVP Commercial, has been a key person in BillerudKorsnäs for several years. Even though Helene will remain in her position for the time being, I already now want to thank Helene for her efforts and wish her good luck for the future”, says Christoph Michalski, President and CEO

Notice of Raute Corporation's Annual General Meeting

RAUTE CORPORATION STOCK EXCHANGE RELEASE 26 FEBRUARY 2021 at 12:30 p.m. NOTICE OF RAUTE CORPORATION’S ANNUAL GENERAL MEETING Raute Corporation’s shareholders are invited to attend the Company’s Annual General Meeting, which will be held on Wednesday, March 31, 2021 at 6 p.m. at Sibelius Hall, Ankkurikatu 7, Lahti, Finland. The reception of the registered participants will begin at 5:30 p.m. In order to lower the risk of infection due to the Covid-19 epidemic, the Annual General Meeting will only be arranged if the number of participants in attendance is low enough such that the

Rare Disease Day 2021: Pandemic illuminates every day social obstacles of living with a rare condition

40 per cent of Swedes with a rare condition, or their family members, state that a relationship has ended due to a rare condition, according to a study by Swedish biopharmaceutical company Sobi. In addition, 63 per cent say that the disease has prevented them from entering a new relationship. It has been difficult to maintain social connections during the ongoing pandemic since activities and contacts outside the home have been restricted to avoid spread of infection. For many of the 400,000 people in Sweden living with rare conditions, restrictions affecting social life and external

Tailwind for Axfood’s sustainability work in 2020

In connection with the publication of Axfood’s Annual and Sustainability Report today, improvements in the area of sustainability have also been summed up. Reduced food waste, fossil-free transports and a higher share of sustainability-labelled products are just a few areas where important progress was made during the past year.Food has never had a greater impact on the climate and environment than today. Axfood is therefore working long-term and systematically with sustainability issues across the entire value chain. “At the same time that the sustainability challenges are increasing in

Change in number of shares and votes in Alligator Bioscience AB

During February 2021, the number of shares and votes in Alligator Bioscience AB (“Alligator”) has increased as a result of the completion of the rights issue of shares resolved upon by the Board of Directors of Alligator on December 15, 2020. Per February 26, 2021, the number of registered shares and votes in Alligator amounts to 85,666,338. For more information, please contact:Per Norlén, CEOPhone: +46 46 540 82 00E-mail: per.norlen@alligatorbioscience.com  Marie Svensson, CFOPhone: +46 46 540 82 03E-mail: marie.svensson@alligatorbioscience.com  This information is such

Citycon’s Sustainability Accounts for 2020 published

CITYCON OYJ Investor News 26 February 2021 at 12.00 hrsCitycon Oyj’s Sustainability Accounts for 2020 has been published today. The Sustainability Accounts provides information on the sustainability issues that matter the most to Citycon and its stakeholders, describes the company’s environmental and social performance, as well as sustainability highlights in 2020. The Sustainability Accounts also includes an interview with the CEO as well as many case examples.The Sustainability Accounts is attached to this release and is also available on the company’s website at https://www.citycon.com/

Conversion of shares in NCC AB

According to NCC’s articles of association, owners of Series A shares are entitled to request that such shares be converted to Series B shares. Conversion reduces the total number of voting rights in the company.During February 2021, 29,083 Series A shares were converted to Series B shares at the request of shareholders, following which the total number of voting rights in the company amounts to 225,131,919. The total number of registered shares in the company amount to 108,435,822, of which 12,966,233 are Series A and 95,469,589 are Series B.  NCC holds 764,267 Series B shares in

Conversion of shares in Skanska AB

In conjunction with a conversion of shares, the company is obliged, according to the Financial Instruments Trading Act (1991:980), to disclose information concerning the change.During February 2021, 2,617 Series A shares were converted to Series B shares at the request of shareholders. Accordingly, the total number of votes in the company totals 597,040,595. The total number of registered shares in the company amounts to 419,903,072, of which 19,681,947 are Series A shares, and 400,221,125 are Series B shares.

There are no items matching the current filter
There are no more items matching the current filter
Back to top